M-CPP and Fenfluramine in Cocaine Addicts - 3
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000314
- Locations
- ๐บ๐ธ
VA Medical Center, Brooklyn, New York, United States
Role of Metabolites in Nicotine Dependence (4) - 13
Phase 2
Completed
- Conditions
- Tobacco Use Disorder
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000296
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1
Phase 1
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000315
- Locations
- ๐บ๐ธ
Johns Hopkins University, Baltimore, Maryland, United States
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
Phase 2
Completed
- Conditions
- Cocaine-Related DisordersOpioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 140
- Registration Number
- NCT00000306
- Locations
- ๐บ๐ธ
University of Texas Health Science Center, Houston, Texas, United States
Risperidone Treatment in Dually-Diagnosed Individuals - 2
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000267
- Locations
- ๐บ๐ธ
New York State Psychiatric Institute, New York, New York, United States
IV Cocaine Abuse: A Laboratory Model - 4
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000215
- Locations
- ๐บ๐ธ
Columbia University, New York, New York, United States
Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13
Phase 1
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000348
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
Phase 2
Completed
- Conditions
- Substance-Related DisordersCocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000245
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath